Long-term outcome of primary percutaneous transluminal coronary angioplasty for low-risk acute myocardial infarction in patients older than 80 years: A single-center, open, randomized trial

American Heart Journal

Volumn 143, Issue 3, 2002, Pages 497-505

  Minai, Kazuo ^a   Horie, Hajime ^a   Takahashi, Masayuki ^a   Nozawa, Masato ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0036191411     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.120778     Document Type: Article

References (45)

1. Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study
2. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials
3. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: Results from the Thrombolysis in Myocardial Infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study
4. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction trial
5. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase
6. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction
7. Improved outcome of elderly patients (75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel
8. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
9. Coronary revascularization after myocardial infarction in the very elderly: Outcomes and long-term follow-up
10. In-vivo validation of on-line and off-line geometric coronary measurements using insertion of stenosis phantoms in porcine coronary arteries
11. An improved procedure for serum creatine phosphokinase determination
12. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
13. Left ventricular volume and mass from single-plane cineangiogram: A comparison of anteroposterior and right anterior oblique methods
14. Determinants and protective potential of coronary collaterals as assessed by angioplasty model
15. Long-term effects of intravenous anistre-plase in acute myocardial infarction: Final report of the AIMS study
16. Biased estimates of expected acute myocardial infarction mortality using Medis Groups admission severity groups
17. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
18. Primary coronary angioplasty for acute myocardial infarction (the primary angioplasty registry)
19. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction
20. Effect of age on outcome with primary angioplasty versus thrombolysis
21. The exclusion of the elderly and women from clinical trials in acute myocardial infarction
22. Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-I trial
23. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
24. Use of reperfusion therapy for acute myocardial infarction in the United States. Data from the National Registry of Myocardial Infarction 2
25. Gender difference in long-term prognosis after myocardial infarction. Clinical characteristics in 1000 patients
26. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years
27. Echocardiographic detection of infarct-localized asynergy and remote asynergy during acute myocardial infarction: Correlation with the extent of angiographic coronary disease
28. Primary coronary angioplasty versus systemic thrombolysis in acute anterior myocardial infarction
29. Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction
30. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction by percutaneous transluminal coronary angioplasty
31. Duration of, and temporal trends (1994-1997) in, prehospital delay in patients with acute myocardial infarction: The second National Registry of Myocardial Infarction
32. Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart
33. Age-dependent effects of ischemia and reperfusion on cardiac function and Ca2 transport in myocardium
34. Exercise cardiac output is maintained with advancing age in healthy human subjects: Cardiac dilatation and increased stroke volume compensate for a diminished heart rate
35. Cardiovascular regulatory mechanisms in advanced age
36. Increased afterload aggravates infarct expansion after acute myocardial infarction
37. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial
38. Angina-induced protection against myocardial infarction in adult and elderly patients: A loss of preconditioning mechamism in the aging heart
39. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
40. Thrombolytic therapy in older patients
41. A comparison of management patterns after acute myocardial infarction in Canada and the United States
42. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables
43. Time to presentation with acute myocardial infarction in the elderly. Associations with race, sex, and socioeconomic characteristics
44. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada